Faes Farma, S.A. (FRA:FFEA)

Market Cap	1.43B +37.5%
Revenue (ttm)	626.99M +22.9%
Net Income	79.63M -28.5%
EPS	0.25 -28.7%
Shares Out	n/a
PE Ratio	17.90
Forward PE	15.29
Dividend	0.14 (3.23%)
Ex-Dividend Date	Jan 8, 2026

Volume	n/a
Average Volume	17
Open	4.495
Previous Close	4.490
Day's Range	4.495 - 4.495
52-Week Range	3.600 - 5.490
Beta	n/a
RSI	41.59
Earnings Date	Apr 30, 2026

About Faes Farma

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securiti...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 1,894
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: FFEA

Financial Performance

In 2025, Faes Farma's revenue was 626.99 million, an increase of 22.93% compared to the previous year's 510.04 million. Earnings were 79.63 million, a decrease of -28.49%.